Elevated parathyroid hormone 44-68 in idiopathic calcium pyrophosphate dihydrate crystal deposition disease. Role of menopause and iron metabolism?
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 18061978.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To examine whether idiopathic calcium pyrophosphate dihydrate (CPPD) crystal deposition disease (CDD) is related to altered parathyroid hormone (PTH) metabolism. Forty-two patients with idiopathic CPPD CDD were compared with 67 controls, 33 of whom were matched for age and sex. Serum PTH 44-68 concentrations were elevated in 29% of patients and were significantly higher in the patients than in their sex- and age-matched controls (Z = -4.664, p < 0.0001). PTH 1-84 levels were normal. Serum calcium, phosphorus, and ferritin levels were normal, but were significantly higher in the patients. Serum PTH 44-68 levels correlated negatively with serum transferrin in female controls aged >or= 45 years, and with transferrin saturation in the female patients. Correlation between serum ferritin and age was linear and positive in the former subjects and quadratic in the latter. Elevated serum concentration of PTH mid-fragments containing the 44-68 region could explain the joint disorders associated with idiopathic CPPD CDD, as shown in genetic hemochromatosis. In female patients the elevation of PTH mid-fragments could be linked to changes in iron metabolism provoked by the menopause.
Medical subject headings
- Chondrocalcinosis
- Ferritins
- Iron
- Parathyroid Hormone
- Peptide Fragments
- Postmenopause